Galapagos | GLPG - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Galapagos

Galapagos reported EUR522.9M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
AstraZeneca AZN:LN USD 24.86B 1.43B
Biogen BIIB:US USD 3.01B 257.9M
Genmab GEN:DC DKK 1.96B 132M
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Incyte Corp INCY:US USD 1.01B 150.97M
Merck MRK:GR EUR 9.56B 43M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Novartis NOVN:VX USD 30.55B 1.89B
Roche Holding ROG:VX CHF 27.24B 170M
UCB UCB:BB EUR 3.11B 216M
Vertex Pharmaceuticals VRTX:US USD 3.03B 284.1M